Susan Krumplitsch joined Womble Bond Dickinson as a partner in its patent prosecution and litigation practice group in Silicon Valley, the firm announced Wednesday.
Krumplitsch represents clients across biotechnology, pharmaceutical, and medical device sectors in patent and trade secret matters, regularly appearing in federal courts nationwide and before the US Patent and Trademark Office in post-grant review proceedings. Her practice spans cutting-edge technologies, including next-generation DNA sequencing, therapeutic monoclonal antibodies, transgenic animals, pharmaceutical formulations, small-molecule drug compounds, mammalian cell lines, biofuels, fungicides, and medical imaging, the firm said.
She joins from DLA Piper, according to her LinkedIn profile.
This story ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.